In patients with postoperative right ventricular outflow tract conduit dysfunction and significant baseline tricuspid regurgitation, transcatheter pulmonary valve replacement appears to yield ...

The findings come on the heels of the US Food and Drug Administration approving the Harmony system (Medtronic) in March as the first nonsurgical heart valve to treat pulmonary valve regurgitation in ...

Edwards Lifesciences announced the approval Monday for management of both pediatric and adult patients with severe pulmonary regurgitation on echocardiography who are candidates for surgical ...

RAPID advances in surgery have made an understanding of the significance of any potentially correctable valvular defect as important as the ability to establish an exact diagnosis. As an isolated ...

Most patients who undergo percutaneous pulmonary valve implantation for right ventricular outflow tract (RVOT) dysfunction achieve acute hemodynamic benefit within 1 month that is sustained out to at ...

For years, innovations in the treatment of pulmonary valve regurgitation have relied on invasive surgical treatments—until now. A device from Medtronic that takes a minimally invasive approach to ...

Pulmonic valve regurgitation occurs when blood leaks abnormally backward from the pulmonary artery through the pulmonic valve into the right ventricle. This can result in right heart failure. Pulmonic ...

University of MIchigan Health C.S. Mott Children's Hospital, part of Ann Arbor-based Michigan Medicine, is among the first in the U.S. to perform a catheter-based pulmonary valve replacement on a ...

Medtronic's Harmony transcatheter pulmonary valve (TPV) was approved Friday for treatment of severe pulmonary valve regurgitation with a native or surgically repaired right ventricular outflow tract ...

The US Food and Drug Administration (FDA) has approved Medtronic's Harmony Transcatheter Pulmonary Valve (TPV) System to treat severe pulmonary regurgitation in pediatric and adult patients who have a ...

The optimal treatment strategy for fluctuating MR is uncertain, but can include a combination of surgery, cardiac resynchronization therapy, and new mitral valve approaches Mitral regurgitation (MR) ...